FDA panel backs bluebird’s CALD gene therapy, despite safety worries
bluebird bio, CALD, fda, gene therapy, rare disease, regulatory
0 Comment
CALD
Bluebird claims EU nod for rare disease therapy Skysona
bluebird bio, CALD, EU, gene therapy, rare disease, regulatory approval
0 Comment
CHMP backs bluebird bio’s gene therapy for rare disease ALD
bluebird bio, CALD, CHMP, EU, gene therapy, rare disease, Skysona
0 Comment
